2‐[(4‐Chloro­phen­yl)hydroxy­meth­yl]‐5,5‐dimethyl‐4‐phenyl‐1,3,2‐dioxaphospho­rinan‐2‐one

By  

Acta Crystallographica Section E, Vol. 62, Iss. 11, 2006-11 ,pp. : o4864-o4865

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐(3‐Chloro­phen­yl)‐2‐cyano‐3‐(4‐hydr­oxy‐3‐meth­oxy‐2‐nitro­phen­yl)prop‐2‐enamide

By  

Acta Crystallographica Section E, Vol. 63, Iss. 3, 2007-03 ,pp. : o1317-o1318

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐{2‐[3‐(2‐Chloro­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]phen­oxy}‐N‐(2,6‐dimethyl­phen­yl)acetamide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 11, 2006-11 ,pp. : o5280-o5281

John Wiley & Sons Inc

Access to resources Recommend Favorite

2‐{2‐[3‐(4‐Chloro­phen­yl)‐1,2,4‐oxadiazol‐5‐yl]phen­oxy}‐N‐(2,6‐dimethyl­phen­yl)acetamide

By  

Acta Crystallographica Section E, Vol. 62, Iss. 10, 2006-10 ,pp. : o4744-o4745

John Wiley & Sons Inc

Access to resources Recommend Favorite

A cocrystal of 1‐(4‐chloro­phen­yl)‐3‐(3,4,5‐trimethoxy­phen­yl)prop‐2‐en‐1‐one and 3‐(3‐chloro‐4,5‐di­meth­oxy­phen­yl)‐1‐(4‐chloro­phen­yl)prop‐2‐en‐1‐one (0.95:0.05)

By  

Acta Crystallographica Section E, Vol. 62, Iss. 7, 2006-07 ,pp. : o2611-o2613

John Wiley & Sons Inc

Access to resources Recommend Favorite